Search 
Wednesday, January 07, 2009 ..:: Clinical Trials ::.. Register  Login
 Clinical Trials Minimize
 Print   
 Search Trials Minimize
 Print   
 Archives Minimize
Study Number:

Search
  
 Most Recent Entries Minimize
All Programs
All Sites - Prevention & Control (101170)
Sponsor: RTOG (0517)

 		By All Programs on 1/7/2009 4:00 AM
Randomized Phase Iii Trial To Evaluate Radiopharmaceuticals And Zoledronic Acid In The Palliation Of Osteoblastic Metastases From Lung, Breast, And Prostate Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
BMT
All Sites - Prevention & Control (101298)
Sponsor: BMT CTN (0603)

 		By BMT on 1/7/2009 4:00 AM
A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients with Hematologic Malignancies

None Available
More...
BMT
All Sites - Prevention & Control (101309)
Sponsor: Gentium (2006-05)

 		By BMT on 1/7/2009 4:00 AM
Defibrotide For Hematopoietic Stem Cell Transplant (SCT) Patient With Severe Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study (Under CFR 312.34)

None Available
More...
BMT
Multiple Sites (100715)
Sponsor: MUSC (100715)

 		By BMT on 1/7/2009 4:00 AM
Allogenic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Pre-transplant Conditioning for Patients Not Suitable for Full-Dose Pre-transplant Conditioning

None Available
More...
Breast
Breast (101072)
Sponsor: Novelos (101072)

 		By Breast on 1/7/2009 4:00 AM
Phase II Study of Neoadjuvant Chemotherapy with NOV-002 and AC Followed by Docetaxel in Patients with Stage IIB-IIIC Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101087)
Sponsor: MUSC (101087)

 		By Breast on 1/7/2009 4:00 AM
Program Evaluation of MUSC Hollings Cancer Center's Avon Patient Navigation Program and Breast Health Navigation.

None Available
More...
Breast
Breast (101160)
Sponsor: ACOSOG (Z0131)

 		By Breast on 1/7/2009 4:00 AM
A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane (25 mg daily), Letrozole (2.5 mg), or Anastrozole (1 mg) in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101171)
Sponsor: CTSU/ECOG (PACCT-1)

 		By Breast on 1/7/2009 4:00 AM
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101172)
Sponsor: SWOG (S0622)

 		By Breast on 1/7/2009 4:00 AM
Phase II Studies of Two Different Schedules of Dasatinib (NSC-732517) in Bone-Metastasis Predominant Metastatic Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101203)
Sponsor: CTSU/ECOG (E5103)

 		By Breast on 1/7/2009 4:00 AM
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
 Print   
Copyright 2007 by Hollings Cancer Center   Terms Of Use  Privacy Statement